Cargando…
Combinations of Immunotherapy and Radiation in Cancer Therapy
The immune system has the ability to recognize and specifically reject tumors, and tumors only become clinically apparent once they have evaded immune destruction by creating an immunosuppressive tumor microenvironment. Radiotherapy (RT) can cause immunogenic tumor cell death resulting in cross-prim...
Autores principales: | Vatner, Ralph E., Cooper, Benjamin T., Vanpouille-Box, Claire, Demaria, Sandra, Formenti, Silvia C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246656/ https://www.ncbi.nlm.nih.gov/pubmed/25506582 http://dx.doi.org/10.3389/fonc.2014.00325 |
Ejemplares similares
-
TGFβ and activin A control regulatory T cells in irradiated tumors
por: Vanpouille-Box, Claire, et al.
Publicado: (2015) -
The TLR7 agonist imiquimod as an adjuvant for radiotherapy-elicited in situ vaccination against breast cancer
por: Demaria, Sandra, et al.
Publicado: (2013) -
Fractionated but not single dose radiation releases key signals of in situ tumor vaccination
por: Vanpouille-Box, Claire, et al.
Publicado: (2014) -
Activin A is upregulated by radiation in breast cancer cells and promotes conversion of CD4 T cells into regulatory T cells
por: Vanpouille-Box, Claire, et al.
Publicado: (2013) -
Successful clinical translation of preclinical combinations of radiation and immunotherapy
por: Formenti, Silvia C., et al.
Publicado: (2013)